Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-06-25 KOVEN ANDREW I Director Grant or award +28,000 28,000
2020-06-25 Chen Hongming Chief Scientific Officer Grant or award +16,000 102,849
2020-06-25 Bazemore Todd Chief Operating Officer Grant or award +19,000 29,000
2020-06-19 Trachtenberg Eric Exercise or conversion +28,901 $5.19 $150K 28,901
2020-06-19 Trachtenberg Eric Exercise or conversion · Stock Option (right to buy) −28,901 136,099
2020-06-09 Reumuth Mary Chief Financial Officer Exercise or conversion +11,520 $2.30 $26K 16,336
2020-06-09 Reumuth Mary Chief Financial Officer Exercise or conversion +5,077 $5.21 $26K 21,413
2020-06-09 Reumuth Mary Chief Financial Officer Exercise or conversion +15,360 $2.30 $35K 36,773
2020-06-09 Reumuth Mary Chief Financial Officer Exercise or conversion +11,520 $2.30 $26K 48,293
2020-06-09 Reumuth Mary Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −11,520 0
2020-06-09 Reumuth Mary Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −5,077 0
2020-06-09 Reumuth Mary Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −15,360 0
2020-06-09 Reumuth Mary Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −11,520 0
2020-06-05 Bazemore Todd Chief Operating Officer Purchase +2 $13.39 $27 2
2020-04-09 Brazzell Romulus K Chief Medical Officer Exercise or conversion +1,880 $0.68 $1K 110,605
2020-04-09 Brazzell Romulus K Chief Medical Officer Exercise or conversion +18,247 $2.30 $42K 128,852
2020-04-09 Brazzell Romulus K Chief Medical Officer Exercise or conversion +47,644 $3.34 $159K 176,496
2020-04-09 Brazzell Romulus K Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −1,880 0
2020-04-09 Brazzell Romulus K Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −18,247 0
2020-04-09 Brazzell Romulus K Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −47,644 13,508

Page 17 of 19 · 378 trades